US Edition
News about Gilead Sciences
Stay current with all the latest and breaking news about Gilead Sciences, compare headlines and perspectives between news sources on stories happening today. In total, 45 stories have been published about Gilead Sciences which Ground News has aggregated in the past 3 months.
Covered Most By
Local News Publishers
Suggest a source
Looking for a source we don't already have? Suggest one here.Top Gilead Sciences News
Stock Markets · United StatesMonster Beverage Corporation (NASDAQ:MNST) shares are trading higher on Friday. On Thursday, the company reported second-quarter results, where net sales increased 11.1% to $2.11 billion from $1.90 billion in the same period last year. Goldman Sachs analyst Bonnie Herzog reiterated the Buy rating on Monster, raising the price forecast from $72 to $73. Also Read: Celsius Holdings Q2 FY2025 Earnings Call Transcript Herzog said expectations were el…See the Story
Why Is Monster Beverage Stock Climbing Friday? - Monster Beverage (NASDAQ:MNST)
100% Center coverage: 3 sources
Gilead Sciences · United StatesBy Dominique Fluker ·The post Inside “The Time Is Now: Let’s End HIV In Our Communities” Press Briefing Presented By Gilead Sciences appeared first on Essence.See the Story
Inside “The Time Is Now: Let’s End HIV In Our Communities” Press Briefing Presented By Gilead Sciences
Coverage: 2 sources
Gilead Sciences · United StatesGilead Sciences Inc. Chief Executive Officer Daniel O’Day said the company’s new HIV prevention drug Yeztugo should be able to gain favorable insurance coverage despite questions about how the Trump administration will handle recommendations for treatments like this.Read Article
Gilead Sciences CEO Says HIV Prevention Drug Offers Clear Value
100% Left coverage: 1 sources
